Mario became a Strategic Partner with ArchiMed in September 2019. Mario has significant credentials and a breadth of experiences in the Life Sciences / Bioprocessing sectors. Mario Philips is the current Chairman of Clean Biologics (a partner company of ArchiMed) and has been the CEO of French biotech Polyneuros since March 2019.
Mario joined Pall in 2014, as part of the Pall acquisition of ATMI Life Sciences. He was appointed to Vice President and General Manager to lead the Single-Use Technologies BU. He was promoted in 2017 to become Vice President and General Manager of Pall Biotech, leading and executing an aggressive investment and growth strategy.
Mario started his career with ATMI in 1999 serving as European Sales Manager for ATMI Analytical Systems. In 2004, Mario was appointed to the position of General Manager of ATMI Packaging ; he was promoted in 2010 to the position of Senior Vice President and General Manager, ATMI Life Sciences.
Mario has also held several board member positions in the Life Sciences industry with Austar Life Sciences (China), Disposable Lab (France) and Artelis (Belgium).
Mario graduated with an Engineering degree in Biochemistry from CTL, Gent (Belgium), and has a postgraduate degree in Marketing from Groep T Leuven (Belgium). Mario is a Belgian citizen. At ArchiMed, Mario is particularly focused on the Bioproduction / Bioprocessing sector.